Richard Brandl

3.3k citations
61 papers · 2.5k indexed · 1 hit paper · h-index 24
Topics
Platelet Disorders and Treatments (13 papers)Cell Adhesion Molecules Research (9 papers)Antiplatelet Therapy and Cardiovascular Diseases (7 papers)

In The Last Decade

Richard Brandl

58 papers receiving 2.5k citations

Hit Papers

Activated transcription factor nuclear factor-kappa B is ...19962026200620161996200400600

Peers

Richard Brandl
Comparison fields: 5 of 118
  • Molecular Biology 891
  • Hematology 539
  • Surgery 532
  • Cardiology and Cardiovascular Medicine 531
  • Immunology 528
Replace Elisabeth M. Battinelli with:
Elisabeth M. Battinelli United States
Bart J.M. van Vlijmen Netherlands
M B Stemerman United States
C. López-Pedrera Spain
Stephen Benoit United States
RI Handin United States
S. Bradley Forlow United States
Jan‐Willem N. Akkerman Netherlands
Daniel T. Eitzman United States
Tomio Kawasaki Japan
Richard Brandl relative to Elisabeth M. Battinelli United States Elisabeth M. Battinelli's profile →
Citations per field
00.5×2.5×
Elisabeth M. Battinelli · 1×
Citations per year

Countries citing papers authored by Richard Brandl

Since Specialization
Citations

This map shows the geographic impact of Richard Brandl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Brandl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Brandl more than expected).

Fields of papers citing papers by Richard Brandl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Brandl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Brandl. The network helps show where Richard Brandl may publish in the future.

Co-authorship network of co-authors of Richard Brandl

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Brandl. A scholar is included among the top collaborators of Richard Brandl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Brandl. Richard Brandl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 22
3 25
4 40
5 22
6 34
7 25
8 145
9 27
10 30
11 8
12 87
13 10
14 126
15 38
16 2
17 34
18 67
19 2
20
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.breakdown →
677

About Richard Brandl

Richard Brandl is a scholar working on Immunology and Allergy, Hematology and Internal Medicine, having authored 61 papers that have together received 2.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (13 papers), Cell Adhesion Molecules Research (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). The work is most often cited by research in Internal Medicine (187 citations), Hematology (539 citations) and Immunology and Allergy (198 citations). Richard Brandl has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include Wolfgang Siess, Patrick A. Baeuerle, D. Neumeier, Gerhard Rogler, Sharon Page, Andreas Bartsch, Korbinian Brand, Christian Kaltschmidt, Michael J. Page and Ruth Knuechel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026